glucagon has been researched along with Fatty Liver in 55 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 14 (25.45) | 18.7374 |
1990's | 8 (14.55) | 18.2507 |
2000's | 10 (18.18) | 29.6817 |
2010's | 16 (29.09) | 24.3611 |
2020's | 7 (12.73) | 2.80 |
Authors | Studies |
---|---|
Barron, M; Fernando, DG; Geurts, AM; Hayes, H; Kindel, TL | 1 |
Bloom, S; Carling, D; Davies, I; Dore, M; Goldin, R; Hope, DCD; Khoo, B; Le Gall, M; McGlone, ER; Owen, B; Siebert, M; Tan, TM | 1 |
Bagger, JI; Demant, M; Holst, JJ; Knop, FK; Kønig, MJ; Langhoff, JL; Lund, A; Rigbolt, K; Strandberg, C; Suppli, MP; van Hall, G; Vilsbøll, T; Wewer Albrechtsen, NJ | 1 |
Andersen, DB; Bisgaard, HC; Dall, M; Eriksen, PL; Galsgaard, KD; Gillum, MP; Gluud, LL; Hassing, AS; Holst, JJ; Hunt, JE; Jepsen, SL; Kjeldsen, SAS; Knop, FK; Kuhre, RE; Pedersen, J; Santos, A; Sulek, K; Torekov, SS; Trammell, SAJ; Treebak, JT; Vasilopoulou, CG; Vilstrup, H; Werge, MP; Wewer Albrechtsen, NJ; Windeløv, JA; Winther-Sørensen, M; Ørskov, C | 1 |
Bagger, JI; Becker, U; Bergmann, SS; Dalsgaard, NB; Demant, M; Foghsgaard, S; Gasbjerg, LS; Gether, L; Gillum, MP; Grønbæk, H; Grøndahl, MFG; Holst, JJ; Knop, FK; Knop, J; Kønig, MJ; Lanng, AR; Strandberg, C; Suppli, MP; Thomasen, M; Vilsbøll, T; Wewer Albrechtsen, NJ | 1 |
Ardévol, A; Beltrán-Debón, R; Blay, M; Grau-Bové, C; Miguéns-Gómez, A; Pinent, M; Rodríguez-Gallego, E; Sierra-Cruz, M; Terra, X | 1 |
Geisler, CE; Renquist, BJ | 1 |
Clemmensen, C; DiMarchi, RD; Finan, B; Hofmann, SM; Jall, S; Müller, TD; Neff, F; Sachs, S; Tschöp, MH | 1 |
Li, J; Li, W; Liang, J; Luan, B; Lv, S; Qiu, X; Zhang, C; Zhang, ZN | 1 |
Knop, FK | 1 |
Bracht, A; Carreño, FO; Constantin, J; Constantin, RP; de Moraes, SMF; Gasparin, FRS; Ghizoni, CVC; Gilglioni, EH; Ishii-Iwamoto, EL; Maeda Júnior, AS; Natali, MRM; Rocha, M; Utsunomiya, KS | 1 |
Feng, W; Gong, M; Ke, Y; Li, M; Su, C; Wang, X; Yang, C; Yuan, P; Zheng, X | 1 |
Fujita, Y; Fukui, K; Hosakawa, Y; Ishibashi, C; Iwahashi, H; Kimura, T; Kozawa, J; Shimomura, I; Yoneda, S | 1 |
Beglinger, C; Bernsmeier, C; Blaser, LS; Heim, MH; Jeker, L; Meyer-Gerspach, AC; Steinert, RE | 1 |
Hao, L; Huang, KH; Ito, K; Lambert, JD; Ross, AC; Sae-tan, S | 1 |
Comhair, TM; Dejong, CH; Garcia Caraballo, SC; Houten, SM; Koehler, SE; Lamers, WH | 1 |
Chen, X; Fang, D; Kim, H; Mendez, R; Zhang, K | 1 |
Bagger, JI; Knop, FK; Lund, A; Suppli, MP; Vilsbøll, T | 1 |
Carr, T; Christian, P; Pashaj, A; Shen, J; Song, Y; Su, Q; Sud, N; Wang, H; Zhang, K; Zhao, M | 1 |
Angelin, B; Bonde, Y | 1 |
Boesch, C; Brandejsky, V; Campos, V; Despland, C; Kreis, R; Schneiter, P; Tappy, L | 1 |
Abuzaid, A; Allen, PS; Beitz, DC; Bobe, G; Coetzee, JF; Koehler, K; Osman, MA | 1 |
Baheza, RA; Berglund, ED; Charron, MJ; Damon, BM; Donahue, EP; Hasenour, CM; Lee-Young, RS; Lustig, DG; Lynes, SE; Swift, LL; Wasserman, DH | 1 |
André, JM; Davail, S; Guy, G; Hoo-Paris, R; Rideau, N | 1 |
Ametaj, BN; Beitz, DC; Bobe, G; Young, JW | 1 |
Beylot, M; Diraison, F; Moulin, P | 1 |
Atsumi, Y; Matsuoka, K; Murata, C; Oka, Y; Suzuki, Y; Taniyama, M | 1 |
Couvelard, A; Fregeville, A; Paradis, V; Vilgrain, V; Warshauer, DM | 1 |
Ametaj, BN; Beitz, DC; Bobe, G; Koehler, KJ; Nafikov, RA; Young, JW | 1 |
Ametaj, BN; Anderson, LL; Beitz, DC; Bobe, G; Young, JW | 1 |
Iwasa, S; Kobayashi, T; Kondo, K; Nihei, J; Ohneda, A | 1 |
Bertics, SJ; Grummer, RR; Reynolds, CK; Studer, VA | 1 |
Angsusingha, K; Likitmaskul, S; Punnakanta, L; Tuchinda, C; Veerakul, K; Wacharasindhu, S; Wasant, P | 1 |
Grønstøl, H; Steen, A; Torjesen, PA | 1 |
Furuhama, K; Yabe, K | 1 |
Beitz, DC; Hippen, AR; Lindberg, GL; Richardson, LF; She, P; Tucker, RW; Young, JW | 1 |
Bosch, F; Casellas, A; Devedjian, JC; George, M; Gros, L; Pelegrín, M; Pujol, A; Visa, J | 1 |
Hippen, AR | 1 |
Bernabucci, U; Bertics, SJ; Besong, SA; Bremmer, DR; Grummer, RR; Trower, SL | 1 |
Imamura, K; Inokuchi, T; Isogai, S; Orita, M; Takao, T | 1 |
Mol, JA; van den Ingh, TS; van der Linde-Sipman, JS; van Toor, AJ; Wensing, T | 1 |
Dayal, R; Fischer, JE; LaFrance, RJ; Li, SJ; McFadden, DW; Nussbaum, MS; Zhang, FS | 1 |
Dayal, R; Fischer, JE; Li, SJ; McFadden, DW; Nussbaum, MS | 1 |
Abe, T; Arai, T; Ichikawa, K; Nagamine, T; Saeki, S; Sakurai, S; Takagi, H; Takahashi, H; Takezawa, J; Yamada, S | 1 |
Dayal, R; Fischer, JE; Gapen, CL; Li, SJ; McFadden, DW; Nussbaum, MS | 1 |
Imamura, T; Inman, L; Koffler, M | 1 |
Isakova, ZS; Karepova, ME; Logimov, AS; Vysotskaia, RA | 1 |
Voskresenskiĭ, ON | 1 |
Cotton, RB; Dhiensiri, K; Glasgow, AM | 1 |
Hilden, M; Juhl, E; Rehfeld, JF | 1 |
Conn, HO; Felig, P; Hendler, R; Joshi, P; Sherwin, R | 1 |
De Oya, M; Grande, F; Prigge, WF; Swenson, DE | 1 |
Beringer von, A; Geyer, G; Mösslacher, H; Tragl, KH; Waldhäusl, W | 1 |
Bunge, HC | 1 |
Brunner, H; Grabner, G; Michalek, P; Paumgartner, G | 1 |
4 review(s) available for glucagon and Fatty Liver
Article | Year |
---|---|
Hepatic lipid accumulation: cause and consequence of dysregulated glucoregulatory hormones.
Topics: Adipose Tissue; Animals; Diet; Endocrine System Diseases; Fatty Liver; Glucagon; Gluconeogenesis; Glucose; Homeostasis; Hormones; Humans; Hydrocortisone; Hyperinsulinism; Lipid Metabolism; Lipids; Lipogenesis; Lipolysis; Liver; Non-alcoholic Fatty Liver Disease; Obesity; Overnutrition; Oxidation-Reduction; Signal Transduction; Virus Diseases | 2017 |
EJE PRIZE 2018: A gut feeling about glucagon.
Topics: Diabetes Mellitus, Type 2; Enteroendocrine Cells; Fasting; Fatty Liver; Gastrointestinal Tract; Glucagon; Glucagon-Secreting Cells; Glucose; Glucose Tolerance Test; Humans; Hyperglycemia; Liver; Proglucagon | 2018 |
Glucagon as a potential therapy for ketosis and fatty liver.
Topics: Animals; Cattle; Cattle Diseases; Dairying; Fatty Liver; Female; Glucagon; Ketosis; Lactation; Pregnancy | 2000 |
[Pancreatic hormones and arteriosclerosis].
Topics: Aging; Animals; Arteriosclerosis; Blood Proteins; Cholesterol; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Dogs; Fatty Acids; Fatty Liver; Glucagon; Guinea Pigs; Hypercholesterolemia; Insulin; Insulin Secretion; Lipotropic Agents; NADP; Obesity; Pancreatectomy; Phosphatidylcholines; Rabbits; Rats; Sterols; Tissue Extracts | 1967 |
5 trial(s) available for glucagon and Fatty Liver
Article | Year |
---|---|
Metabolic Effects of Replacing Sugar-Sweetened Beverages with Artificially-Sweetened Beverages in Overweight Subjects with or without Hepatic Steatosis: A Randomized Control Clinical Trial.
Topics: Adult; Blood Glucose; Body Mass Index; Diet; Fatty Acids, Nonesterified; Fatty Liver; Female; Glucagon; Humans; Insulin; Lactic Acid; Male; Meals; Nutritive Sweeteners; Obesity; Overweight; Postprandial Period; Sweetening Agents; Treatment Outcome; Triglycerides; Uric Acid; Young Adult | 2017 |
Chronic metabolic responses of postpartal dairy cows to subcutaneous glucagon injections, oral glycerol, or both.
Topics: 3-Hydroxybutyric Acid; Administration, Oral; Animals; Blood Glucose; Cattle; Cattle Diseases; Drug Synergism; Fatty Acids, Nonesterified; Fatty Liver; Female; Glucagon; Glycerol; Injections, Subcutaneous; Insulin; Liver; Postpartum Period | 2010 |
Prevention of fatty liver in transition dairy cows by subcutaneous injections of glucagon.
Topics: Acetoacetates; Animals; Blood Glucose; Blood Urea Nitrogen; Body Composition; Cattle; Cattle Diseases; Cholesterol; Eating; Fatty Acids, Nonesterified; Fatty Liver; Female; Glucagon; Injections, Subcutaneous; Insulin; Lactation; Lipids; Liver; Milk; Nitrogen; Phospholipids; Postpartum Period; Triglycerides; Urea | 2006 |
Exogenous glucagon effects on health and reproductive performance of lactating dairy cows with mild fatty liver.
Topics: Animals; Cattle; Cattle Diseases; Fatty Liver; Female; Glucagon; Health Status; Injections, Subcutaneous; Lactation; Mastitis, Bovine; Postpartum Period; Pregnancy; Reproduction | 2007 |
Etiology of fatty liver in dairy cattle: effects of nutritional and hormonal status on hepatic microsomal triglyceride transfer protein.
Topics: Animal Feed; Animals; Blood Glucose; Carrier Proteins; Cattle; Cattle Diseases; Cells, Cultured; Fatty Acids, Nonesterified; Fatty Liver; Female; Glucagon; Hepatocytes; Insulin; Lactation; Liver; Male; Nutritional Status; Pregnancy; Pregnancy Complications; Propylene Glycol; RNA, Messenger; Time Factors; Triglycerides | 2000 |
46 other study(ies) available for glucagon and Fatty Liver
Article | Year |
---|---|
Sleeve Gastrectomy Improves High-Fat Diet-Associated Hepatic Steatosis Independent of the Glucagon-like-Petpide-1 Receptor in Rats.
Topics: Animals; Diet, High-Fat; Fatty Liver; Female; Gastrectomy; Glucagon; Glucagon-Like Peptide Receptors; Glucagon-Like Peptide-1 Receptor; Glucose; Male; Mice; Obesity; Rats; Rats, Inbred Lew | 2022 |
Sleeve gastrectomy causes weight-loss independent improvements in hepatic steatosis.
Topics: Animals; Blood Glucose; Fatty Liver; Gastrectomy; Glucagon; Mice; Obesity; Weight Loss | 2023 |
Glucagon Resistance at the Level of Amino Acid Turnover in Obese Subjects With Hepatic Steatosis.
Topics: Adult; Aged; Aged, 80 and over; Amino Acids; Blood Glucose; Fatty Liver; Glucagon; Hormones; Humans; Hyperammonemia; Insulin; Male; Middle Aged; Obesity; Pancreas; Somatostatin | 2020 |
Glucagon acutely regulates hepatic amino acid catabolism and the effect may be disturbed by steatosis.
Topics: Adult; Amino Acids; Animals; Blood Glucose; Fatty Liver; Female; Glucagon; Glucagon-Secreting Cells; Glucose; Hepatocytes; Humans; Insulin; Insulin Resistance; Liver; Male; Mice; Mice, Inbred C57BL; Middle Aged; Non-alcoholic Fatty Liver Disease; Rats; Rats, Wistar; Receptors, Glucagon; Urea | 2020 |
Metabolic effects of 1-week binge drinking and fast food intake during Roskilde Festival in young healthy male adults.
Topics: Adult; Aspartate Aminotransferases; Binge Drinking; Blood Glucose; C-Peptide; C-Reactive Protein; Denmark; Diet; Elasticity Imaging Techniques; Fast Foods; Fatty Liver; Fibroblast Growth Factors; Glucagon; Glucose Tolerance Test; Growth Differentiation Factor 15; Holidays; Humans; Insulin Resistance; Liver; Male; Young Adult | 2021 |
Grape-Seed Proanthocyanidin Extract Reverts Obesity-Related Metabolic Derangements in Aged Female Rats.
Topics: Adiposity; Animals; Blood Glucose; Disease Models, Animal; Fatty Liver; Female; Glucagon; Grape Seed Extract; Insulin; Obesity; Proanthocyanidins; Rats; Rats, Wistar; Weight Loss | 2021 |
Monomeric GLP-1/GIP/glucagon triagonism corrects obesity, hepatosteatosis, and dyslipidemia in female mice.
Topics: Adiposity; Animals; Diet, High-Fat; Dyslipidemias; Eating; Fatty Liver; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Male; Mice; Mice, Inbred C57BL; Obesity; Sex Factors | 2017 |
Glucagon-induced extracellular cAMP regulates hepatic lipid metabolism.
Topics: Animals; Cells, Cultured; Cyclic AMP; Fatty Acids; Fatty Liver; Gene Expression Regulation; Glucagon; Hepatocytes; Lipid Metabolism; Mice; Multidrug Resistance-Associated Proteins; Obesity; Oxidation-Reduction | 2017 |
Cafeteria Diet Feeding in Young Rats Leads to Hepatic Steatosis and Increased Gluconeogenesis under Fatty Acids and Glucagon Influence.
Topics: Animals; Diet; Energy Intake; Fatty Acids; Fatty Liver; Feeding Behavior; Glucagon; Gluconeogenesis; Glucose; Lactic Acid; Male; Obesity; Oxygen Consumption; Pyruvic Acid; Rats; Rats, Wistar | 2018 |
Antidiabetic Activity and Potential Mechanism of Amentoflavone in Diabetic Mice.
Topics: Animals; Biflavonoids; Biomarkers; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Fasting; Fatty Liver; Glucagon; Glucose; Glucose Tolerance Test; Hypoglycemic Agents; Insulin; Lipid Metabolism; Lipids; Lipoproteins; Liver; Mice; Muscle, Skeletal; Oxidation-Reduction; Phosphorylation | 2019 |
Pancreatic fat is related to the longitudinal decrease in the increment of C-peptide in glucagon stimulation test in type 2 diabetes patients.
Topics: Adipose Tissue; Aged; Biomarkers; C-Peptide; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Fatty Liver; Female; Follow-Up Studies; Gastrointestinal Agents; Glucagon; Glucose Tolerance Test; Humans; Longitudinal Studies; Male; Pancreatic Diseases; Prognosis | 2020 |
Glucose-induced glucagon-like Peptide 1 secretion is deficient in patients with non-alcoholic fatty liver disease.
Topics: Case-Control Studies; Fatty Liver; Female; Glucagon; Glucagon-Like Peptide 1; Glucose; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Non-alcoholic Fatty Liver Disease | 2014 |
Shifts in dietary carbohydrate-lipid exposure regulate expression of the non-alcoholic fatty liver disease-associated gene PNPLA3/adiponutrin in mouse liver and HepG2 human liver cells.
Topics: Animals; Cell Line, Tumor; Diet, High-Fat; Dietary Carbohydrates; Fatty Liver; Gene Expression; Glucagon; Glucose; Hep G2 Cells; Hepatocytes; Humans; Insulin; Lipid Metabolism; Lipids; Lipogenesis; Liver; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease | 2014 |
High-protein diets prevent steatosis and induce hepatic accumulation of monomethyl branched-chain fatty acids.
Topics: Animals; Blood Glucose; Cholesterol; Diet, High-Fat; Diet, Protein-Restricted; Dietary Fats; Dietary Proteins; Fatty Acids, Nonesterified; Fatty Liver; Female; Fibroblast Growth Factors; Glucagon; Insulin; Leptin; Lipid Metabolism; Liver; Male; Mice; Mice, Inbred C57BL; Palmitic Acids; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Phospholipids; Sex Factors; Transcription Factors; Triglycerides; Up-Regulation | 2014 |
Lysine Acetylation of CREBH Regulates Fasting-Induced Hepatic Lipid Metabolism.
Topics: Acetylation; Animals; Cell Line; Cyclic AMP Response Element-Binding Protein; Energy Metabolism; Fasting; Fatty Liver; Glucagon; Hepatocytes; Histone Acetyltransferases; Hyperlipidemias; Lipid Metabolism; Liver; Mice; Mice, Inbred C57BL; Mice, Knockout; Mutagenesis, Site-Directed; p300-CBP Transcription Factors; PPAR gamma; Protein Structure, Tertiary; Sirtuin 1; Transcriptional Activation | 2015 |
Involvement of steatosis-induced glucagon resistance in hyperglucagonaemia.
Topics: Anemia; Diabetes Mellitus, Type 2; Fatty Liver; Glucagon; Glucagon-Secreting Cells; Humans; Models, Biological | 2016 |
Glucagon regulates hepatic lipid metabolism via cAMP and Insig-2 signaling: implication for the pathogenesis of hypertriglyceridemia and hepatic steatosis.
Topics: Animals; Cell Line, Tumor; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Fatty Liver; Glucagon; Hep G2 Cells; Hepatocytes; Humans; Hypertriglyceridemia; Lipid Metabolism; Lipogenesis; Membrane Proteins; Mice, Inbred C57BL; Mice, Knockout; Signal Transduction; Sterol Regulatory Element Binding Protein 1 | 2016 |
Metabolic Syndrome: One Speckled Stone Kills a Flock of Birds?
Topics: Animals; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Fatty Liver; Glucagon; Hormones; Humans; Metabolic Syndrome; Triiodothyronine | 2017 |
Hepatic glucagon action is essential for exercise-induced reversal of mouse fatty liver.
Topics: Animals; Body Weight; Dietary Fats; Disease Progression; Fatty Liver; Glucagon; Lipid Metabolism; Liver; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Receptors, Glucagon; Signal Transduction | 2011 |
Pancreatic hormonal and metabolic responses in overfed ducks.
Topics: Animals; Blood Glucose; Body Weight; Crosses, Genetic; Ducks; Fatty Liver; Female; Glucagon; Hyperphagia; Insulin; Lipoprotein Lipase; Male; Organ Size; Pancreas; Triglycerides | 2003 |
Potential treatment of fatty liver with 14-day subcutaneous injections of glucagon.
Topics: Animals; Blood Glucose; Body Weight; Cattle; Cattle Diseases; Eating; Fatty Acids, Nonesterified; Fatty Liver; Female; Glucagon; Injections, Subcutaneous; Insulin; Lactation; Liver; Milk; Postpartum Period; Triglycerides | 2003 |
Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease.
Topics: Adult; Carbon Isotopes; Cholesterol; Fatty Acids, Nonesterified; Fatty Liver; Female; Glucagon; Humans; Insulin; Isotope Labeling; Lipid Mobilization; Liver; Male; Middle Aged; Palmitic Acid; Reference Values; Triglycerides | 2003 |
A case of type 2 diabetes with high levels of plasma and urinary C-peptide.
Topics: Adult; Biomarkers; C-Peptide; Diabetes Mellitus, Type 2; Fatty Liver; Glucagon; Glucose Clamp Technique; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Kidney; Male; Radiography | 2004 |
Metastatic insulinoma and glucagonoma from the pancreas responsible for specific peritumoral patterns of hepatic steatosis secondary to local effects of insulin and glucagon on hepatocytes.
Topics: Adult; Fatty Liver; Female; Glucagon; Glucagonoma; Hepatocytes; Humans; Insulin; Insulin Secretion; Insulinoma; Liver; Liver Neoplasms; Pancreatic Neoplasms; Radiography | 2005 |
Measurement of glucagon in human plasma by enzyme immunoassay.
Topics: Colonic Neoplasms; Diabetes Mellitus; Fatty Liver; Glucagon; Hepatitis; Humans; Immunoenzyme Techniques; Intestinal Polyps; Obesity; Radioimmunoassay | 1983 |
Effect of prepartum propylene glycol administration on periparturient fatty liver in dairy cows.
Topics: 3-Hydroxybutyric Acid; Animals; Blood Glucose; Cattle; Cattle Diseases; Fatty Acids, Nonesterified; Fatty Liver; Female; Glucagon; Hydroxybutyrates; Insulin; Lactation; Liver; Pregnancy; Pregnancy Complications; Propylene Glycol; Propylene Glycols; Triglycerides | 1993 |
Congenital generalized lipodystrophy, a case report.
Topics: Blood Platelets; Child, Preschool; Fatty Liver; Female; Genes, Recessive; Glucagon; Humans; Lipodystrophy; Liver; Muscle, Skeletal; Nuclear Family; Platelet Aggregation; Reference Values; Syndrome | 1995 |
Glucose and insulin responses to glucagon injection in dairy cows with ketosis and fatty liver.
Topics: Animals; Blood Glucose; Cattle; Cattle Diseases; Fatty Liver; Female; Glucagon; Injections, Intravenous; Insulin; Ketosis | 1997 |
Application of hepatic tolerance tests to the functional reserve assessment in rat models of fatty liver.
Topics: Animals; Cholesterol; Cholesterol, Dietary; Choline Deficiency; Cyclic AMP; Disease Models, Animal; Ethionine; Fatty Liver; Galactosemias; Glucagon; Half-Life; Hepatectomy; Indocyanine Green; Liver; Liver Function Tests; Male; Phospholipids; Rats; Rats, Sprague-Dawley | 1998 |
Alleviation of fatty liver in dairy cows with 14-day intravenous infusions of glucagon.
Topics: 3-Hydroxybutyric Acid; Animals; Blood Glucose; Body Composition; Cattle; Cattle Diseases; Fatty Acids, Nonesterified; Fatty Liver; Female; Glucagon; Infusions, Intravenous; Insulin; Ketosis; Lactation; Liver; Milk; Postpartum Period; Triglycerides | 1999 |
Transgenic mice overexpressing insulin-like growth factor-II in beta cells develop type 2 diabetes.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 2; Dietary Fats; Fatty Liver; Gene Expression; Glucagon; Glucose; Glucose Tolerance Test; Hyperinsulinism; Hyperplasia; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Islets of Langerhans; Mice; Mice, Inbred C57BL; Mice, Transgenic; Obesity; Promoter Regions, Genetic; Rats; Recombinant Fusion Proteins; RNA, Messenger | 2000 |
Resistance to ketosis in moderately obese patients: influence of fatty liver.
Topics: 3-Hydroxybutyric Acid; Adult; Blood Glucose; Epinephrine; Fatty Acids, Nonesterified; Fatty Liver; Female; Glucagon; Glycerol; Humans; Hydroxybutyrates; Immunity, Innate; Insulin; Ketone Bodies; Ketosis; Male; Obesity; Time Factors | 1992 |
Experimental induction of fasting hypoglycaemia and fatty liver syndrome in three Yorkshire terrier pups.
Topics: Animals; Blood Glucose; Breeding; Dog Diseases; Dogs; Fasting; Fatty Liver; Female; Glucagon; Hematocrit; Hydrocortisone; Hypoglycemia; Insulin; Ketone Bodies; Lipids; Liver; Male; Syndrome | 1991 |
Addition of L-glutamine to total parenteral nutrition and its effects on portal insulin and glucagon and the development of hepatic steatosis in rats.
Topics: Animals; Body Weight; DNA; Fatty Liver; Glucagon; Glutamine; Insulin; Intestine, Small; Lipid Metabolism; Liver; Male; Parenteral Nutrition, Total; Portal Vein; Proteins; Rats; Rats, Inbred Strains | 1990 |
Reversal of hepatic steatosis in rats by addition of glucagon to total parenteral nutrition (TPN).
Topics: Animals; Fatty Liver; Glucagon; Insulin; Lipid Metabolism; Liver; Liver Function Tests; Male; Parenteral Nutrition, Total; Portal Vein; Rats; Rats, Inbred Strains | 1989 |
[Clinical evaluation of the glucagon test in fatty liver].
Topics: Blood Glucose; Cyclic AMP; Fatty Liver; Glucagon; Humans; Insulin | 1985 |
Addition of glucagon to total parenteral nutrition (TPN) prevents hepatic steatosis in rats.
Topics: Animals; Fatty Acids; Fatty Liver; Glucagon; Insulin; Lipid Mobilization; Liver; Male; Parenteral Nutrition, Total; Rats; Rats, Inbred Strains | 1988 |
Deleterious effects of chronic intravenous glucose overload and their possible prevention by glucagon.
Topics: Animals; Dogs; Fatty Liver; Glucagon; Glucose; Injections, Intravenous | 1987 |
[Endocrine function of the pancreas in chronic pancreatitis].
Topics: Alcoholism; Blood Glucose; C-Peptide; Chronic Disease; Fatty Liver; Female; Glucagon; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Male; Pancreatitis; Proinsulin | 1985 |
Reye syndrome. 3. The hypoglycemia.
Topics: Animals; Blood Glucose; Brain Diseases; Fatty Liver; Glucagon; Gluconeogenesis; Glucose; Glycogen; Growth Hormone; Haplorhini; Humans; Hypoglycemia; Insulin; Liver; Mice; Pyruvates; Rats; Reye Syndrome | 1973 |
Carbohydrate metabolism in alcohol-induced fatty liver. Evidence for an abnormal insulin response to glucagon in alcoholic liver disease.
Topics: Adult; Aged; Alcoholism; Blood Glucose; Fatty Liver; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Liver Cirrhosis; Male; Middle Aged | 1973 |
Hyperglucagonemia in Laennec's cirrhosis. The role of portal-systemic shunting.
Topics: Adolescent; Adult; Aged; Alanine; Alcoholism; Amino Acids; Ammonia; Blood Glucose; Esophageal and Gastric Varices; Fatty Liver; Glucagon; Humans; Insulin; Liver; Liver Circulation; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Portacaval Shunt, Surgical | 1974 |
Role of glucagon on fatty liver production in birds.
Topics: Animals; Blood Glucose; Ducks; Fatty Acids, Nonesterified; Fatty Liver; Female; Geese; Glucagon; Glucose; Lipids; Liver; Male; Oleic Acids; Triglycerides | 1971 |
[On the cause and treatment of the senile diabetes].
Topics: Aged; Animals; Blood Glucose; Diabetes Complications; Diabetes Mellitus; Diabetic Retinopathy; Diet Therapy; Exercise Therapy; Fatty Liver; Glucagon; Humans; Hypoglycemic Agents; Injections, Intramuscular; Insulin; Liver Glycogen; Obesity; Rabbits | 1968 |
[The outcome of the glucagon test in obesity].
Topics: Adolescent; Adult; Aged; Blood Glucose; Fatty Liver; Glucagon; Humans; Injections, Intravenous; Liver Function Tests; Liver Glycogen; Middle Aged; Obesity | 1968 |
[Evaluation of liver function by means of the glucagon test].
Topics: Adolescent; Adult; Aged; Blood Glucose; Catheterization; Cholestasis; Fatty Liver; Glucagon; Hepatic Veins; Hepatitis A; Humans; Hyperbilirubinemia; Liver; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Liver Glycogen; Middle Aged | 1968 |